---
layout: post
title: "Malaria: Developing Drugs for Treatment; Draft Guidance for Industry; Availability"
date: 2026-02-04 21:49:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-18407
original_published: 2025-09-23 00:00:00 +0000
significance: 8.00
---

# Malaria: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 23, 2025 00:00 UTC
**Document Number:** 2025-18407

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Malaria: Developing Drugs for Treatment." The purpose of this draft guidance is to assist sponsors in the overall development program for drug and biological products for the treatment of malaria, caused by clinically relevant Plasmodium species.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/23/2025-18407/malaria-developing-drugs-for-treatment-draft-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2025-18407

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
